BIOMAT Database Logo BIOMAT Database Logo

[Programmed use of hemoperfusion through activated charcoal in treatment of patients with terminal uremia]. 1977

E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina

UI MeSH Term Description Entries
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Hemoperfusion with activated charcoal].
January 1982, Nihon rinsho. Japanese journal of clinical medicine,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Hemoperfusion through activated charcoal in Reye's syndrome].
August 1982, Ceskoslovenska pediatrie,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Theophylline poisoning: use of hemoperfusion with activated charcoal].
April 1988, Revista clinica espanola,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Treatment of comatose patients by extracorporeal hemoperfusion with activated charcoal].
July 1976, MMW, Munchener medizinische Wochenschrift,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[First experience with the use of extracorporeal hemoperfusion through activated charcoal in children].
January 1975, Eksperimental'naia khirurgiia i anesteziologiia,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Hemoperfusion through activated charcoal in the complex treatment of systemic lupus erythematosus].
January 1981, Terapevticheskii arkhiv,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
Use of activated charcoal for hemoperfusion in Dutch rabbits.
March 1981, American journal of veterinary research,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Use of hemoperfusion over activated charcoal in acute poisoning].
June 1979, Vnitrni lekarstvi,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
[Current concepts of hemoperfusion through activated charcoal in the treatment of internal diseases].
January 1983, Terapevticheskii arkhiv,
E R Levitskiĭ, and A A Dmitriev, and A V Pliaskina
Treatment of extrahepatic occlusive jaundice with activated charcoal hemoperfusion in dogs.
January 1976, Acta hepato-gastroenterologica,
Copied contents to your clipboard!